AI in Healthcare

The GLP-1 revolution is here — but who gets access? New data shows 29 to 31 million U.S. adults are now using these drugs, yet coverage remains deeply unequal. Lower-income patients, who stand to benefit most, are being left behind due to insurance restrictions and delayed generic entry. This isn’t just a pricing issue — it’s a systemic failure in care delivery and equity. AI has the potential to reframe this crisis: by predicting long-term health savings, optimizing risk pools, and identifying underserved populations. But only if algorithms are built with fairness, not just efficiency, at their core. This insight comes from a University of Pennsylvania LDI panel discussion on October 23, 2026, published today: https://ldi.upenn.edu/our-work/research-updates/the-glp-1-dilemma-medical-breakthrough-meets-financial-reality/ How can AI help ensure that breakthroughs don’t become privileges? Let’s discuss. Source: https://ldi.upenn.edu/our-work/research-updates/the-glp-1-dilemma-medical-breakthrough-meets-financial-reality/ View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.